Enveric Biosciences, Inc. 8-K

What Happened

• On May 15, 2026, Enveric Biosciences, Inc. (ENVB) announced a corporate update and reported its financial results for the quarter ended March 31, 2026. The company furnished a press release as Exhibit 99.1 to a Form 8-K filed the same day, reporting results of operations and financial condition under Item 2.02.

Key Details

• Filing date: May 15, 2026.
• Reporting period: Quarter ended March 31, 2026.
• Disclosure: Press release furnished as Exhibit 99.1 and incorporated by reference in the Form 8-K.
• Form 8-K section: Item 2.02 (Results of Operations and Financial Condition).

Why It Matters

• This 8-K provides Enveric’s official quarterly results and any corporate updates management chose to disclose; those details (revenue, net income/loss, cash position, and any guidance) are contained in the furnished press release.
• Retail investors should review the press release (Exhibit 99.1) to see the company’s recent financial performance and any changes to business outlook or liquidity that could affect investment decisions.